Donelan, Jill http://orcid.org/0009-0003-2761-5304
Douglas, Susan
Willson, Ariane
Lester, Tyrena
Daly, Stephanie http://orcid.org/0000-0002-5239-4828
Article History
Accepted: 15 February 2024
First Online: 4 April 2024
Declarations
:
: At the time of this publication, Jill Donelan is employed by Mirah, a Measurement-Based Care (MBC) technology company, and therefore declares a potential conflict of interest. The project was designed and all data collection, review, and analysis were completed between 2021 and 2023, while Jill Donelan was employed as a clinical supervisor for the Child Partial Hospitalization Program in the department of Psychiatry at Baystate Health, with no financial relationship with Mirah. Vanderbilt University and Susan Douglas receive compensation related to the Peabody Treatment Progress Battery; and Susan Douglas has a financial relationship with MIRAH, and both are Measurement -Based Care (MBC) tools. The author declares a potential conflict of interest. There is a management plan in place at Vanderbilt University to monitor that this potential conflict does not jeopardize the objectivity of Dr. Douglas’ research.
: This study was reviewed by the Baystate Medical Center Institutional Board, which determined that this project met federal criteria for exemption and provided a waiver of the requirement for HIPAA authorization.